AU2001244903A1 - Inhaler - Google Patents

Inhaler

Info

Publication number
AU2001244903A1
AU2001244903A1 AU2001244903A AU2001244903A AU2001244903A1 AU 2001244903 A1 AU2001244903 A1 AU 2001244903A1 AU 2001244903 A AU2001244903 A AU 2001244903A AU 2001244903 A AU2001244903 A AU 2001244903A AU 2001244903 A1 AU2001244903 A1 AU 2001244903A1
Authority
AU
Australia
Prior art keywords
canister
ofthe
engagement member
loading element
canister engagement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001244903A
Other versions
AU2001244903B2 (en
Inventor
Jorgen Rasmussen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0006525.0A external-priority patent/GB0006525D0/en
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2001244903A1 publication Critical patent/AU2001244903A1/en
Application granted granted Critical
Publication of AU2001244903B2 publication Critical patent/AU2001244903B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Description

ΓNHALER
The present application relates to an inhaler for delivery of medicament from a canister, in particular to an actuation mechanism for actuating the canister held in the inhaler.
Inhalers are commonly used to deliver a wide range of medicaments. The inhaler holds a canister of medicament which is actuatable, for example by compression, to deliver a dose of medicament. Some known inhalers are provided with an actuation mechanism for actuating the canister. The mechanism may be breath-actuated, ie. arranged to actuate the canister in response to inhalation at the mouthpiece. Typically a breath-actuated inhaler includes a loading mechanism for loading a resilient loading element with an actuation force for compression ofthe canister. A triggering mechanism may be provided to hold the resilient loading element against compression ofthe canister, the triggering mechanism releasing the resilient loading element upon inhalation.
In such an actuation mechanism the resilient loading element must provide a sufficiently high force to compress the canister. In general, the force generated by a resilient loading element decreases as it expands during the compression stroke ofthe canister. For example if the resilient loading element is a spring, the force generated will decrease linearly with the expansion ofthe spring in proportion to its spring constant. Therefore, to provide sufficient force at the end ofthe compression stroke ofthe canister, the force generated by the resilient loading element at the beginning ofthe stroke is larger still. This is the loaded position in which the actuation mechanism will usually be stored, ready for use. However, it is undesirable to store the actuation mechanism with the resilient loading element applying a high force to the other elements holding the loading element in its loaded position, such as the triggering mechanism. This is because the high force can cause creep in the various components subject to the high force, particularly if the components are made of plastic which is desirable to reduce costs and simplify manufacture. Over time such creep can distort the components of the actuation mechanism. This can have the effect of causing improper actuation of the canister, for example by causing actuation at an incorrect inhalation flow or, in the worst case, preventing operation ofthe actuation mechanism at all.
According to the present invention, there is provided an inhaler for delivery of medicament from a canister which is compressible to deliver a dose of medicament, the inhaler comprising: a housing for holding a canister; a canister engagement member engageable with a canister held in the housing to compress the canister; a loading mechanism for loading a resilient loading element which is arranged, when loaded, to bias the canister engagement member to compress the canister; a triggering mechanism arranged to hold the canister engagement member against compression ofthe canister and triggerable to release the canister engagement member, wherein the linkage between the resilient loading element and the canister engagement member is arranged to reduce the force applied by the canister engagement member to the triggering mechanism when held by the triggering mechanism.
The present invention is based on the appreciation that it is possible to arrange the linkage between the resilient loading element and the canister engagement member to reduce the force above other canister engagement members and to the triggering mechanism in the loaded state. There are many different ways of arranging the linkage to achieve this.
To allow better understanding, an inhaler which embodies the present invention will now be described by way of non-limitative example with reference to the accompanying drawings, in which:
Fig. 1 is a side view ofthe inhaler;
Fig. 2 is a cross-sectional view ofthe inhaler illustrating the housing and duct; Fig. 3 is a side view of the duct;
Fig. 4 is a side view of the canister and duct assembled together; Fig. 5 is an exploded view ofthe canister, collar and duct; Fig. 6 is a cross-sectional view ofthe canister and dust assembled together; Fig. 7is a view from the side and rear ofthe actuation mechanism; Fig. 8 is a view from the rear ofthe spindle; Fig. 9 is a view from the side, rear and above showing the arrangement of the resilient loading element;
Fig. 10 is a schematic view ofthe cam surfaces formed on the spindle; Fig. 11 is a view from the side and rear ofthe triggering mechanism; Fig. 12 is a side view ofthe triggering mechanism; Fig. 13 is a side view ofthe locking mechanism;
Fig. 14A to 14F are graphs showing the angular positions ofthe elements of the actuation mechanism during its operation sequence;
Figs. 15 to 22 are views ofthe actuation mechanism in various states during its operation sequence with views from opposite sides being suffixed by the letters A, B respectively;
Fig. 23 is a graph showing forces generating during the compression stroke ofthe canister;
Figs. 24A to 24C are views of an alternative arrangement for the torsion spring; and Figs. 25 and 26 are views of an alternative linkage between the torsion spring and the canister engagement lever.
As illustrated in Fig. 1, the inhaler has a housing 1 comprising an upper portion 19 and a lower portion 20. As illustrated in the cross-sectional view of Fig. 2, the upper housing portion 19 is a hollow shell which holds a canister 2 of medicament having a generally cylindrical body 3 held with its axis in a predetermined direction, vertical in Fig. 2. The upper housing portion 19 houses an actuation mechanism for actuating the canister 2 which will be described in more detail below.
The interior ofthe upper housing portion 19 is open to the atmosphere by means of air inlets 51 formed in the upper wall 52 ofthe upper housing portion 19. The location ofthe air inlets 51 minimises occlusion by the users hand which will normally grip the sides ofthe housing 1 and not cover the upper wall 52.
The canister 2 is compressible to deliver a dose of medicament. In particular the canister 2 has a valve stem 4 which is compressible relative to the body 3 to deliver a dose of medicament from the valve stem 4. The canister is of a known type including a metering chamber which captures a defined volume the medicament from the body 3 ofthe canister 2. This volume of medicament is delivered as a metered dose from the valve stem 4 on compression ofthe valve stem 4 relative to the body 3. The valve stem 4 is weakly biassed outwardly by an internal valve spring (not shown) to reset the canister 2 after compression for refilling the metering chamber.
The lower housing portion 20 is a hollow shell connected to the upper housing portion 19 by a sliding joint (not shown) which allows the lower portion 20 to be separated in the direction of the arrow in Fig. 1 by the user gripping textured surfaces 21 formed on the upper and lower housing portions 19 and 20. A cap 22 is hinged to the lower housing portion 20 by a flexible joint 23 to cover and uncover a mouthpiece 5 protruding from the lower housing portion 20.
As shown in Fig. 2, the lower housing portion 20 houses a duct 24 which is integrally formed with the mouthpiece 5, as illustrated in isolation in Fig. 3.
The duct 24 is assembled with a canister 2 as shown in Figs. 4 to 6. The duct 24 receives a nozzle block 11 in an opening 25. The valve stem 4 ofthe canister is received in the nozzle block 11 which is arranged to direct a dose of medicament delivered from the valve stem 4 out ofthe inhaler through the mouthpiece 5. The duct 24 and nozzle block 11 are separately formed. This allows each to be manufactured and subsequently assembled. This produces manufacturing and logistical savings because it facilitates different nozzle block designs being incorporated with a single duct design and vice versa.
A collar 26 is permanently connected to the canister 2. The collar 26 includes an annular retaining ring 27 permanently fitted around a necked portion 28 ofthe canister body 3. The retaining portion 27 prevents removal ofthe collar 26 from the canister such that the collar 26 is removed and replaced together with the canister 2. However, the retaining portion 27 and the canister 2 have a small degree of relative movement along the axis ofthe canister 5 to allow compression ofthe canister body 2 towards the valve stem 4.
The collar 26 further includes a front panel 29 integrally formed with the retaining ring 27. When the canister 2 is inserted in the housing 1, the front panel 29 ofthe collar 26 closes an opening formed between the upper housing portion 19 and the lower portion 20 and therefore forms a part ofthe outer wall ofthe housing 1. Accordingly, the presence or absence ofthe front panel 29 provides a visual indication to the user of whether or not a canister 2 has been inserted in the canister, because the collar 26 is permanently connected to the canister 2. A pair of catch arms 30 integrally formed with the front panel 29 ofthe sides ofthe collar 26 catch the interior surface ofthe upper housing portion 19 to hold the collar 26 and the canister 2 in the upper housing portion 19.
The lower housing portion 20 has a stud 50 which locates the end ofthe nozzle block 11 as shown in Fig. 2 to hold the lower housing portion 20 and the duct 24 in place relative to one another. However, the lower housing portion 20 is not retained on the duct 24, so may be removed from the upper housing portion 19 leaving the canister 2 inserted in the upper housing portion 19 and the duct 24 held on the canister 2 by the valve stem 4 being inserted in the nozzle block 11. The duct 24 and nozzle block 11 may subsequently be slid off the valve stem 4 for cleaning or replacement. The canister 2 and collar 26 may be slid out from the upper housing portion 19 after depression of the catch arms 30. Subsequently a replacement canister 2 and collar 26 may be inserted.
Typically a new duct 24 and nozzle block 11 will be provided to the user with each new canister 2 so that the duct 24 and mouthpiece 5 are regularly replaced to prevent damage or dirt building up over time. The duct 24 has an opening 31 at its end opposite from the mouthpiece 5.
As shown in Fig. 2, the upper housing portion 19 holds a flap duct 32 which extends from a flow inlet 33 to a flap 13 which forms part ofthe triggering mechanism for the actuation mechanism as described in detail below. Therefore the duct 24 housed in the lower housing portion 19 and the flap duct 32 together define a composite duct shaped to direct the inhalation flow from the mouthpiece 5 to the flap 13. The composite duct formed by the duct 24 and the flap duct 32 is shaped to control the flow to the flap 13 to provide appropriate flow characteristics for proper operation ofthe flap 13.
The inhaler is further provided with an actuation mechanism 6. To assist understanding, a general description ofthe overall structure and operation ofthe actuation mechanism 6 will first be given.
An actuation force for compressing the canister 2 is stored in a resilient loading element in the form of a torsion spring 7. To load the torsion spring 7, the actuation mechanism 6 includes a loading mechanism consisting of a loading member in the form of a rotatable spindle 8 and two contact members in the form of buttons 9 which protrude from the housing as shown in Fig. 1. Depression ofthe buttons 9 towards one another, relative to the housing 1 , drives the loading member 8 to load the torsion spring 7 through a cam arrangement between the buttons 9 and spindle 8. The torsion spring 7 biasses compression ofthe canister 2 by engaging a canister engagement member in the form of a lever 10 which depresses the body 3 of the canister towards the stem 4 held in the nozzle block 1 1.
To allow storage ofthe actuation force in the torsion spring 7 after loading, the actuation mechanism 6 includes a triggering mechanism. This includes a locking lever 12 which holds the canister engagement lever 10 against compression ofthe canister 2. To release the canister engagement lever 10, the triggering mechanism further includes a vane in the form of a flap 13 which in a rest state holds the locking lever 12 in place. Inhalation at the mouthpiece 5 moves the flap 13 to release the locking member 12. This in turn releases the canister engagement lever 10 allowing the torsion spring 7 to drive compression ofthe canister 2.
The actuation mechanism 6 further includes a locking mechanism which locks the spindle 8 after loading ofthe torsion spring 7, thereby holding the torsion spring 7 in its loaded state before triggering and locking the canister in its compressed state after triggering. The locking mechanism includes a catch 14 which, in a locking position, catches the spindle 8 and holds the torsion spring 7 in its loaded state. The locking mechanism further includes an intermediate member 15. A resilient biassing element in the form of a spring 16 is provided between the catch 14 and the intermediate member 15 to bias the catch 14 towards its locking position. The spring 16 allows deflection ofthe catch 14 by the spindle 8 during loading ofthe torsion spring 7. Prior to inhalation the intermediate member 15 is held in place by the canister engagement lever 10. Upon inhalation at the mouthpiece 5, the flap 13 engages the intermediate member 15 to hold it in place. After compression by the canister engagement lever 10, the canister 2 is locked in its compressed state by the catch 14 ofthe locking mechanism holding the spindle 8 in place. When the level of inhalation at the mouthpiece falls below a predetermined threshold, the flap 13 releases the intermediate member 15 to unload the biassing element 16 which in turn allows the catch 14 to release the spindle 8. After release by the catch 14, the spindle 8, torsion spring 7 and canister engagement lever 10 move upwardly and the canister resets. Now there will be given a detailed description ofthe actuation mechanism 6, the entirety of which is illustrated in Fig. 7 and parts of which are illustrated in Figs.
8 to 13.
The loading mechanism is illustrated in Fig. 8 and consists of a rotatable spindle 8 and two contact members in the forms of buttons 9 at both ends. The spindle 8 is rotatably mounted in the upper housing portion 19 about an axis orthogonal to the axis of the cylindrical body 3 ofthe canister 2. The spindle 8 has a pair of cam surfaces 8a disposed on opposite sides ofthe rotational axis ofthe spindle 8. The buttons 9 are mounted in the housing to be movable in a movement direction parallel to the rotational axis ofthe spindle 8. The buttons 9 each have a pair of inwardly projecting cam followers 9a which each engage a respective cam surface 8a ofthe spindle 8. The cam arrangement ofthe cam surfaces 8a and the cam followers 9a between the spindle 8 and the buttons 9 causes depression ofthe buttons
9 to drive rotation ofthe spindle 8.
As illustrated in Fig. 9, the torsion spring 7 which forms the resilient loading element is disposed with its coils 7a encircling a central cylindrical surface 8b ofthe spindle 8. A catch arm 8c protrudes radially from the spindle 8. A first leg 7b ofthe torsion spring 7 is restrained by the catch arm 8c so that the movement ofthe spindle 8 driven by the buttons 9 loads the torsion spring 7.
As illustrated schematically in Fig 10, the cam surfaces 8a have a non-linear shape which causes the gearing ratio ofthe amount of driven movement ofthe spindle 8 to the amount of movement ofthe buttons 9 to be a non-linear function of the rotational position ofthe spindle 8. The major portion 8b of each cam surface 8a is shaped with increasing pitch to compensate for the increased reactive loading force applied by the torsion spring 7 to the spindle 8 as the buttons 9 are depressed. In particular, they are shaped such that the necessary force applied to the buttons is substantially constant so the user feels a linear resistance. As the torsion spring 7 has a linear spring constant, this is achieved by shaping the major portion 8b of each cam surface 8a such that the gearing ratio is inversely proportion to the rotational position ofthe spindle 8.
Optionally, the outermost portion ofthe cam surfaces 8a which are contacted by the cam followers 9a during the initial portion ofthe driven movement ofthe spindle may have a decreased pitch, for example as illustrated by the dotted lines 8e. This is to reduce the gearing ratio relative to the subsequent major portion 8b. In this way the user initially feels a low resistance to movement ofthe buttons 9. This improves the feel perceived by the user and also assists the user in applying force.
Another option is to provide the final portion ofthe cam surface 8a with a detent, for example as illustrated by the dotted lines 8d. When the end ofthe cam followers 9a reach the detent 8d, the cam surface 8a ofthe spindle 8 no longer exerts a force urging the buttons outwardly on the buttons 9. At this position the detent 8d is urged by the torsion spring 7 against the side ofthe cam followers 9a and therefore holds the buttons 9 in their innermost position. This prevents the buttons 9 from loosely sliding back and forth after the torsion spring 7 has been loaded.
As shown in Fig. 9, the torsion spring 7 engages a canister engagement lever 10 which is pivotally mounted to the interior ofthe housing about an axis 10a. The canister engagement lever 10 is generally U-shaped with two parallel sides 10b connected by a cross piece 10c. A bar lOd extending between the two sides 10b bears on the body 5 ofthe canister 2. A mount lOe formed on the cross-piece 10c is engaged by the second leg 7c ofthe torsion spring 7, whereby loading ofthe torsion spring 7 biasses the lever 10 to compress the canister 2. The canister engagement lever 10 is biassed upwardly by a reset spring (not shown), which may be arranged as a torsion spring on the axis 10a, but this is weaker than the torsion spring 7.
The torsion spring 7, spindle 8 and canister engagement lever 10 are all rotatable about axis orthogonal to the cylindrical axis ofthe body 5 of the canister 2. This provides a simple and reliable loading mechanism particularly because ofthe arrangement ofthe torsion spring 7 with its coils 7a encircling the spindle 8. Some or all of these elements could alternatively be linearly movable in a plane parallel to the cylindrical axis ofthe body 5 ofthe canister 2 to achieve a loading mechanism which is equally simple to construct. However rotatable elements are preferred from the point of view of reliability in repeated use ofthe actuation mechanism 6.
On the other hand, the movement of the buttons in a direction orthogonal to the cylinder axis ofthe body 3 ofthe canister 2 assists the user in application of force to the loading mechanism. As typical for inhalers, the housing 1 extends in the direction ofthe cylindrical axis ofthe body 3 ofthe canister 2, so may be easily held in the palm of a hand with the buttons 9 protruding from either side. Thus the buttons 9 are easily depressed between a finger and thumb. Alternatively a single button could be provided allowing loading in a similar manner by the user pressing the button and the housing on the opposite side to the button. Either configuration also allows loading by laying the inhaler on a surface and applying force for example with the palm of a hand. This facilitates loading by a user with limited finger control or movement, for example a chronic arthritis sufferer. The actuation member mechanism 6 includes a triggering mechanism as illustrated in Figs. 11 and 12 which allows storage ofthe actuation force in the torsion spring 7 after loading.
The triggering mechanism includes a locking lever 12 which is pivotably mounted on an axle 17 extending across the interior of the housing 1. The locking lever 12 has a notch 12a adjacent the axle 17. In a reset state shown in Fig. 12. the notch 12a holds a protrusion lOf protruding from the cross-piece 10c of the canister engagement lever 10, thereby holding the lever 10 against compression ofthe canister 2. The locking lever 12 is weakly biassed towards the position shown in Figs. 11 and 12 by a reset spring 34 arranged as a torsion spring on the axle 17.
The triggering mechanism further includes a vane in the form of a flap 13 which is rotatably mounted on an axle 18 extending across the interior ofthe housing 1. The flap 13 biassed by a reset spring (not shown), which may be arranged as a torsion spring on the axle 18, towards the position shown in Fig. 12. The flap 13 has a locking lever engagement surface 13a which protrudes from a block 13b positioned above the axle 18. In the position shown in Fig. 12, the engagement surface 13a engages a contact surface 12b formed on the end ofthe locking lever 12 distal from the axle 17 to hold the locking lever 12 in place holding the canister engagement lever 10.
The flap 13 is disposed in the composite duct formed by the duct 24 and the flap duct 32 extending from the mouthpiece 5 with a flap portion 13c extending across the composite duct at the opposite end from the mouthpiece 5, where the duct opens into the interior ofthe housing 1. Therefore, the flap 13 is responsive to inhalation at the mouthpiece 5.
Inhalation of the mouthpiece draws the flap portion 13c into the flap duct 32 (clockwise in Fig. 2 and anticlockwise in Fig. 12). Such rotation ofthe flap 13 allows the locking lever engagement surface 13a to move out of contact with the contact surfacel2b ofthe locking lever 12.
The upper housing portion 19 also mounts a button 35 disposed adjacent the flap 13 above the axle 18 so that depression ofthe button 35 rotates the flap 13 in the same direction as inhalation at the mouthpiece 5. Therefore, the button 35 allows the actuation mechanism 6 to be manually released without inhalation at the mouthpiece
5, for example to allow actuation of the canister 2 for testing.
When the canister engagement lever 10 is loaded by the torsion spring 7, release ofthe locking lever 12 by the flap 13 allows the canister engagement lever 10 to be driven to compress the canister 2. The protrusion 1 Of deflects the locking lever 12 (anticlockwise in Fig. 12) as the canister engagement lever 10 passes.
As illustrated in Fig. 13, the actuation mechanism 6 further includes a locking mechanism for locking the spindle 8 after loading ofthe torsion spring 7. The locking mechanism comprises a catch 14 and an intermediate member 15 which are both pivotally mounted on the axle 17, adjacent the locking lever 12. Before compression ofthe canister 2, the intermediate member 15 is held in the position illustrated in Fig. 13 by the cross-piece 10c ofthe canister engagement lever 10 contacting a first contact surface 15a adjacent the axle 17. A resilient biassing element in the form of a torsion spring 16 is connected between the catch 14 and the intermediate member 15 and loaded to bias the catch 14 towards its locking position shown in Fig. 13. The catch 14 has a notch 14a adjacent the axle 17 for engaging the arm 8c of the spindle 8 after rotation to the position illustrated in Fig. 13 where the torsion spring 7 is loaded. In this position, the loading provided by the spring 16 prevents release ofthe spindle 8 and thereby holds the torsion spring 7 in its loaded state. Before loading, the arm 8c ofthe spindle 8 is positioned above the end 14b ofthe catch 14 distal from the axle 17. When the spindle 8 is driven downwards by depression ofthe buttons 9, the arm 8c ofthe spindle engages the end 14b ofthe catch 14 and deflects the catch 14 by compressing the spring 16 to allow passage of the arm 8c ofthe spindle 8. **-
The flap 13 further includes a stud 13d protruding from the block 13b on the opposite side ofthe axle 18 from the locking lever engagement surface 13 a. Upon inhalation at the mouthpiece 5, the flap 13 moves to the position illustrated in Fig. 13 where the stud 13d engages a second contact surface 15b ofthe intermediate member 15 distal from the axle 17. Prior to this point, the stud 13d does not contact the second contact surface 15b but the intermediate member 15 has been held in place by the canister engagement lever 10. Movement ofthe flap 13 triggers the triggering mechanism to release the canister engagement member 10 which moves downwards out of contact with the intermediate member 15. However, the stud 13d catches the contact surface 15b and so continues to hold the intermediate member 15 with the spring 16 loaded. Accordingly, the catch 14 remains in its locking position locking the spindle 8 by engagement ofthe arm 8c of the spindle 8 in the notch 14a ofthe catch 14. Subsequently, when the level of inhalation ofthe mouthpiece falls below a predetermined threshold, the flap moves out of contact with the intermediate member
15 (clockwise in Fig. 13). The level ofthe predetermined threshold at which the flap 13 releases the intermediate member 15 is controlled by the shape ofthe second contact surface 15b ofthe intermediate member 15.
After release by the flap 13, the intermediate member 15 is driven by spring
16 which unloads (clockwise in Fig. 13). Such unloading ofthe spring 16 reduces the force by which the catch 14 is biassed towards its locking position. Accordingly, the force ofthe torsion spring 7 acting on the canister engagement lever 10 is sufficient to force the catch arm 8c ofthe spindle 8 out ofthe notch 14a.
Accordingly, the spindle 8, the torsion spring 7 and canister engagement lever 10 are able to move upwardly biassed by the reset spring acting on the canister engagement lever 10, thereby allowing the canister to reset.
The sequence of operation ofthe actuation mechanism 6 will now be described with reference to Figs. 14 to 22. Fig. 14A to 14F are graphs showing the angular positions ofthe various elements ofthe actuation mechanism 6. In particular, Fig. 14A illustrates the angular position of the flap 13; Fig. 14B illustrates the angular position ofthe locking lever 12; Fig. 14C illustrates the angular position ofthe canister engagement lever 10; Fig. 14D illustrates the angular position ofthe intermediate member 15; Fig. 14E illustrates the angular position ofthe catch 14; and Fig. 14F illustrates the angular position ofthe spindle 8. Various states and positions ofthe actuation mechanism 6 are labelled by the letters A to R in Figs. 14 and Figs. 15 to 22 illustrate the actuation mechanism 6 in some of these states with the views from opposite sides being suffixed by the letters A and B, respectively. The sequence commences in state A as shown in Figs. 15 in which the torsion spring 7 has been loaded by depression ofthe buttons 9 and the spindle 8 is locked by the catch 14. In state A, the canister engagement lever is 10 held by the locking lever 12. The inhaler may be stored with the actuation mechanism 6 in state A. At position B, the user starts to inhale. The flap 13, being responsive to such inhalation, starts to move. The shape ofthe contact surface 12b allows the locking lever 12 to start moving slowly. The actuation mechanism 6 is now in state C illustrated in Figs. 16.
At position D, the locking lever engagement surface 13a of the flap 13 releases the contact surface 12b ofthe locking lever 12. Accordingly, the canister engagement member 10 under the loading ofthe torsion spring 7 starts to rotate downwards deflecting the locking lever 12 against its reset spring as the projection 1 Of moves out ofthe notch 12a. The actuation mechanism is now in state E illustrated in Figs. 17.
At position F, the canister engagement lever 10 moves out of contact with the first contact surface 15a at the intermediate member 15 which therefore starts to move under the biassing of spring 16. However, the intermediate member 15 only moves a short way because at position G it is caught by the flap 13, in particular by the bar 13d of the flap 13 contacting the second contact surface 15b. This contact stops the movement ofthe flap 13 and the intermediate member 15. The movement ofthe canister engagement lever 10 compresses the body 3 ofthe canister 2 relative to the stem 4 held in the nozzle block 11, thereby causing the canister 2 to deliver a dose of medicament. The nozzle block 11 directs the dose of medicament out ofthe mouthpiece at which the user is inhaling. The actuation mechanism 6 is now in state H illustrated in Figs. 18. When the level of inhalation starts to fall, at position I the flap 13 under the biassing of its reset spring starts to move back closing the duct. This movement of the flap 13 causes the intermediate member 15 to move slightly due to the shape of the second contact surface 15b.
When the level of inhalation falls below the predetermined threshold, at position J the bar 13d ofthe flap 13 moves out of contact with the second contact surface 15b. This releases the intermediate member 15. Under the action ofthe spring 16, the intermediate member 15 moves to unload the spring 16. The actuation mechanism 6 is now in state K illustrated in Figs. 19.
At position L the load on the catch 14 from the spring 16 reduces to the extent that the catch 15 can no longer hold the spindle 8. The force of the torsion spring 7 forces the arm 8c ofthe spindle 8 upwards and out of engagement with the notch 14a ofthe catch 14. This forces the catch 14 backwards. The actuation mechanism 6 is now in state M illustrated in Figs. 20.
At position N, the torsion spring 7 reaches its neutral, unloaded position, so there is no load between the canister engagement lever 10 and the spindle 8. Thereafter the canister engagement lever 10 and the torsion spring 8 are moved under the action ofthe reset spring biassing the canister engagement lever 10.
At position O, the canister engagement lever 10 contacts the first contact surface 15a ofthe intermediate member 15 and forces it backwards. The actuation mechanism is now in state P illustrated in Figs. 21. This loads the spring 16 and pushes the catch 14 towards its locking position until the catch 14 contacts the arm 8c ofthe spindle 8 which has now passed out of the notch 14a.
At position Q, the projection lOf of the canister engagement lever 10 moves into the notch 12a ofthe locking lever 12 which snaps back into its locking position under the action of its reset spring. The actuation mechanism 6 is now in state R in Figs. 22. In state R, the canister is reset and ready to be compressed again for delivery of the next dose, but the actuation mechanism 6 is relaxed with the torsion spring 7 unloaded. The rotation ofthe spindle 8 has forced the buttons 9 outwards to the position illustrated in Figs. 22. The actuation mechanism 6 is ready to be loaded once again by compression of the buttons 9. The user is instructed to do this immediately after inhalation, so that the canister may be stored in a state ready to be used simply by inhaling at the mouthpiece 5.
When the user depresses the buttons 9 at position S, this drives the spindle 8 downwards . The arm 8c ofthe spindle 8 deflects the catch 14 slightly against the loaded spring 16 until the arm 8c moves into the notch 14a. This allows the spring 16 to snap the catch 14 into its locking position.
Fig. 23 shows various forces generated during the compression stroke ofthe canister 2 after the canister engagement lever 10 has been released by the triggering mechanism.
The resistive force generated by the canister 2 is illustrated by line 36. This has two phases. In the first phase I, the resistive force rises steeply because it is derived from both compression ofthe internal valve spring and compression of gaskets in the canister 2 resulting in a large overall spring constant. In the second phase II, the resistive force rises more gently, because the gaskets cease to have an effect so the spring constant is derived solely from the compression ofthe internal valve spring.
It is essential that the force applied to the canister exceeds the resistive force or else the canister 2 will cease to be compressed. The force applied by the torsion spring 7 will decrease as it expands over the compression stroke ofthe canister 2, typically linearly. Therefore, the torsion spring 7 is selected so that the force generated, as shown by line 37 in Fig. 23, exceeds the force required to compress the canister 2 at the end ofthe compression stroke, which is where the resistive force is greatest. The force applied by the torsion spring 7 is higher still at the beginning of the compression stroke in which state the torsion spring 7 is held when the device is loaded. This high force can create creep in the parts holding the torsion spring in its compressed state when the parts are made of plastic which is desirable to simplify manufacture and reduce costs. In particular, those parts are the canister engagement lever 10 and lever 12 ofthe triggering mechanism which hold the lever 10 against compression ofthe canister 2 and also the spindle 8 and catch 14 ofthe locking mechanism which locks the spindle 8 after loading ofthe torsion spring 7. It has been appreciated that it is possible to provide a linkage between the torsion spring 7 and the canister engagement member 10 to reduce the force applied by the canister engagement member 10 ofthe triggering mechanism in the loaded state. Some possible linkages which may be introduced as modifications to the actuation mechanism described above with reference to Figs. 7 to 22 are described below.
A first linkage is illustrated in Figs. 24A to 24C in which the canister engagement member 10 and the spindle 8 are illustrated schematically. In this arrangement, the torsion spring 7 is pivotally connected to the ends ofthe canister engagement member 10 and the spindle 8 and the torsion spring 7 is freely suspended so is free to move without its coils being restrained as occurs in the structure of Fig. 7 because the torsion spring 7 is mounted on the spindle 8. The torsion spring 7 has linear characteristics, but is arranged so that in the loaded state ofthe device shown in Fig. 24A, the force applied by the torsion spring acts in a direction at a very narrow angle to the canister engagement lever 10, (or more precisely to the line between the axis of rotation of the canister engagement lever 10, and its pivotal connection .with the torsion spring 7). Therefore, a large component ofthe force applied by the torsion spring 7 is applied through the bearing ofthe canister engagement lever 10 and only a small component of this force creates a torque tending to rotate the canister engagement lever 10. Therefore, the force applied by the canister engagement lever 10 to the locking lever 12 is reduced. Similarly the force applied to the torsion spring 7 to the spindle 8 also acts at an oblique angle to the line between the axis of rotation of the spindle 8 ofthe pivotal connection between the spindle 8 and torsion spring 7. This reduces the component of that force tending to rotate the spindle 8.
After the canister engagement lever 10 is released by the locking lever 12, the torsion spring 7 causes the canister engagement lever 10 to rotate downwardly as illustrated in Fig. 24B and 24C. As the canister engagement lever 10 rotates, it draws the torsion spring 7 down and changes the orientation ofthe torsion spring 7. Consequently the torsion spring 7 applies a force to the canister engagement lever 10 at a steadily increasing angle to the canister engagement lever 10. Therefore, the component of the force on the torsion spring 7 which creates a torque to rotate the canister engagement lever 10 rises, whereby the force applied to the canister 2 also rises.
In this way, it is possible to control the force applied by the torsion spring 7 to the canister 2 to be at the level shown by the line 38 in Fig. 23. It will be seen the applied force 38 always exceeds the resistive force generated by the canister 2 which is necessary to compress the canister 2. Nonetheless the linkage limits the force 38 when the actuation mechanism 6 is loaded ready for use, because the bearings carry this load ofthe canister engagement member 10.
A second possible linkage is illustrated in Figs. 25 and 26 in which and intermediate member 39 is provided between the torsion spring 7 and the canister engagement lever 10. The intermediate member 39 is pivotally mounted to the interior ofthe housing about an axis 39a. The torsion spring 7 engages the upper surface 39b ofthe intermediate member 39a for downward biassing. The intermediate member 39 and the canister engagement lever 10 engage one another through a cam arrangement which consists of a cam surface 39c on the lower surface ofthe intermediate member 39 and a cam follower lOg protruding upwardly from the canister engagement lever 10. The shape ofthe cam surface 39c controls the force applied to the canister engagement lever 10. In particular, the cam surface is arranged to reduce this force in the loaded state illustrated in Fig. 25. After the canister engagement lever 10 is released by the locking lever 12, it rotates as illustrated in Fig. 26 and the force applied to the canister engagement lever 10 increases. By appropriately shaping the cam surface 39c it is possible to generate any desired force profile.

Claims (19)

1. An inhaler for delivery of medicament from a canister which is compressible to deliver a dose of medicament, the inhaler comprising: a housing for holding a canister; a canister engagement member engageable with a canister held in the housing to compress the canister; a loading mechanism for loading a resilient loading element which is arranged, when loaded, to bias the canister engagement member to compress the canister; a triggering mechanism arranged to hold the canister engagement member against compression of the canister and triggerable to release the canister engagement member, wherein the linkage between the resilient loading element and the canister engagement member is arranged to reduce the force applied by the canister engagement member to the triggering mechanism when held by the triggering mechanism.
2. An inhaler according to claim 1, said resilient loading element is pivotally connected to said canister engagement member.
3. An inhaler according to claim 1 or 2, wherein said resilient loading element is a torsion spring.
4 . An inhaler according to claim 3, wherein said torsion spring is freely suspended.
5. An inhaler according to any one ofthe preceding claims, wherein the loading mechanism drives a loading member coupled to the resilient loading element to load the resilient loading element and further comprises a locking mechanism arranged to hold the loading element in a loaded state; and the resilient loading element is pivotally connected to said loading member.
6. An inhaler according to claim 1, wherein the said linkage includes a cam arrangement for reducing said force.
7. An inhaler according to claim 6, wherein said linkage includes an intermediate member biassed by said resilient loading element, when loaded, to engage the canister engagement member, said cam arrangement being provided between the intermediate member and the canister engagement member.
8. An inhaler according to claim 7, wherein said intermediate member is rotatable.
9. An inhaler according to claim 7 or 8, wherein said canister engagement member is rotatable.
10. An inhaler according to any one of claims 6 to 9, wherein said cam arrangement consists of a cam surface provided on said intermediate member and a cam follower provided on said canister engagement member.
11. An inhaler according to claim 1 , wherein said linkage includes: an intermediate member biassed by said resilient loading element, when loaded, to engage the canister engagement member; and a mechanical linkage between the canister engagement member and the intermediate member arranged to provide said reduction in the force at the beginning of the stroke of the canister engagement member.
12. An inhaler for delivery of medicament from a canister which is compressible to deliver a dose of medicament, the inhaler comprising: a housing for holding a canister; a loading mechanism for loading a resilient loading element which is arranged, when loaded, to bias compression ofthe canister; a triggering mechanism arranged to hold the resilient loading element against compression ofthe canister and triggerable to release the resilient loading element, wherein the linkage between the resilient loading element and the triggering mechanism is arranged to reduce the force applied by the resilient loading element to the triggering mechanism when held by the triggering mechanism.
13. An inhaler according to claim 12, wherein the said linkage includes a cam arrangement for reducing said force.
14. An inhaler according to claim 13, wherein said linkage includes: a canister engagement member engageable with a canister held in the housing to compress the canister, the triggering mechanism engaging the canister engagement; an intermediate member biassed by said resilient loading element, when loaded, to engage the canister engagement member, said cam arrangement being provided between the intermediate member and the canister engagement member.
15. An inhaler according to claim 14, wherein said intermediate member is rotatable.
16. An inhaler according to claim 14 or 15, wherein said canister engagement member is rotatable.
17. An inhaler according to any one of claims 14 to 16, wherein said cam arrangement consists of a cam surface provided on said intermediate member and a cam follower provided on said canister engagement member.
18. An inhaler according to claim 12, wherein said linkage includes: a canister engagement member engageable with a canister held in the housing to compress the canister, the triggering mechanism engaging the canister engagement; an intermediate member biassed by said resilient loading element, when loaded, to engage the canister engagement member; and a mechanical linkage between the canister engagement member and the intermediate member arranged to provide said reduction in the force at the beginning ofthe stroke ofthe canister engagement member.
19. An inhaler constructed and arranged to operate substantially as hereinbefore described with reference to the accompanying drawings.
AU2001244903A 2000-03-18 2001-03-16 Inhaler Ceased AU2001244903B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0006525.0 2000-03-18
GBGB0006525.0A GB0006525D0 (en) 2000-03-18 2000-03-18 Inhaler
PCT/SE2001/000557 WO2001070313A1 (en) 2000-03-18 2001-03-16 Inhaler

Publications (2)

Publication Number Publication Date
AU2001244903A1 true AU2001244903A1 (en) 2001-12-13
AU2001244903B2 AU2001244903B2 (en) 2005-05-05

Family

ID=9887878

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001244903A Ceased AU2001244903B2 (en) 2000-03-18 2001-03-16 Inhaler
AU4490301A Pending AU4490301A (en) 2000-03-18 2001-03-16 Inhaler

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU4490301A Pending AU4490301A (en) 2000-03-18 2001-03-16 Inhaler

Country Status (14)

Country Link
US (1) US6755190B2 (en)
EP (1) EP1267973B1 (en)
JP (1) JP2003527218A (en)
CN (1) CN1204936C (en)
AT (1) ATE303173T1 (en)
AU (2) AU2001244903B2 (en)
BR (1) BR0109313B1 (en)
CA (1) CA2401594C (en)
DE (1) DE60113079T2 (en)
DK (1) DK1267973T3 (en)
ES (1) ES2247083T3 (en)
GB (1) GB0006525D0 (en)
PT (1) PT1267973E (en)
WO (1) WO2001070313A1 (en)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040237961A1 (en) * 1995-06-08 2004-12-02 Snow John Medlin Inhalation actuated device for use with metered dose inhalers (MDIs)
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US6823863B2 (en) * 2000-03-18 2004-11-30 Astrazeneca Ab Inhaler
US6948494B1 (en) * 2000-05-10 2005-09-27 Innovative Devices, Llc. Medicament container with same side airflow inlet and outlet and method of use
AU2001287924A1 (en) * 2000-09-29 2002-04-08 Pa Knowledge Limited Pressure-responsive means and associated method of manufacture
EP1494732B1 (en) 2002-03-20 2008-01-30 MannKind Corporation Inhalation apparatus
AU2003212529B2 (en) * 2002-03-22 2008-07-10 Clinical Designs Limited Can fixture
EP1369139A1 (en) 2002-06-03 2003-12-10 3M Innovative Properties Company Dose indicators and dispensing canister-indicator assemblies
GB0304000D0 (en) * 2003-02-21 2003-03-26 Clinical Designs Ltd Dispenser
GB0327112D0 (en) * 2003-11-21 2003-12-24 Clincial Designs Ltd Dispenser and reservoir
GB0328859D0 (en) * 2003-12-12 2004-01-14 Clinical Designs Ltd Dispenser and counter
DK1786784T3 (en) 2004-08-20 2011-02-14 Mannkind Corp Catalysis of diketopiperazine synthesis
PL2322180T3 (en) 2004-08-23 2015-10-30 Mannkind Corp Diketopiperazine salts for drug delivery
GB0425518D0 (en) 2004-11-19 2004-12-22 Clinical Designs Ltd Substance source
GB0428204D0 (en) 2004-12-23 2005-01-26 Clinical Designs Ltd Medicament container
GB0518400D0 (en) 2005-09-09 2005-10-19 Clinical Designs Ltd Dispenser
CN104324366B (en) 2005-09-14 2016-10-05 曼金德公司 Method for preparation of drug based on improving the active agent affinity to crystalline microparticle surfaces
MX360812B (en) 2006-02-22 2018-11-16 Mannkind Corp A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent.
US8225790B2 (en) 2007-01-02 2012-07-24 Astrazeneca Ab Inhaler 624
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
DE202009018480U1 (en) 2008-06-13 2012-01-26 Mannkind Corp. Dry powder inhaler and drug delivery system
MX2010014240A (en) 2008-06-20 2011-03-25 Mankind Corp An interactive apparatus and method for real-time profiling of inhalation efforts.
TWI532497B (en) 2008-08-11 2016-05-11 曼凱公司 Use of ultrarapid acting insulin
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
GB0904059D0 (en) 2009-03-10 2009-04-22 Euro Celtique Sa Counter
GB0904040D0 (en) 2009-03-10 2009-04-22 Euro Celtique Sa Counter
US8538707B2 (en) 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
KR101875969B1 (en) 2009-06-12 2018-07-06 맨카인드 코포레이션 Diketopiperazine microparticles with defined specific surface areas
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
RU2571331C1 (en) 2010-06-21 2015-12-20 Маннкайнд Корпорейшн Systems and methods for dry powder drug delivery
BR122020008875B8 (en) 2011-04-01 2022-12-06 Mannkind Corp BLISTER PACKAGING AND METHOD OF MANUFACTURING A BLISTER PACKAGE
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
CA2852536A1 (en) 2011-10-24 2013-05-02 Mannkind Corporation Methods and compositions for treating pain
KR102264177B1 (en) 2012-07-12 2021-06-11 맨카인드 코포레이션 Dry powder drug delivery systems and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
BR112015023168B1 (en) 2013-03-15 2021-08-10 Mannkind Corporation COMPOSITION OF 3,6-BIS(N-FUMARYL-4-AMINOBUTYL)-2,5-CRYSTALLINE DICETOPIPERAZINE, METHOD OF PRODUCTION OF 3,6-BIS(N-FUMARYL-4-AMINOBUTYL)-2,5-DICETOPIPERAZINE PARTICLES AND USE OF A CRYSTALLINE DICETOPIPERAZINE COMPOSITION
GB201304784D0 (en) * 2013-03-15 2013-05-01 Euro Celtique Sa Dispenser
CN114848614A (en) 2013-07-18 2022-08-05 曼金德公司 Heat stable dry powder pharmaceutical compositions and methods
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
PT3632373T (en) * 2013-08-20 2023-10-24 Boehringer Ingelheim Vetmedica Gmbh Inhaler
GB2519781A (en) * 2013-10-30 2015-05-06 British American Tobacco Co An Inhaler
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN105031777B (en) * 2015-07-30 2018-11-09 中山市美捷时包装制品有限公司 A kind of countable dosed administration actuator of the safety with buffer unit
CN105013052B (en) * 2015-07-30 2018-11-09 中山市美捷时包装制品有限公司 It is a kind of to fall to spray the countable dosed administration actuator arrangement of assembly with impact-absorbing shell
WO2017112748A1 (en) 2015-12-21 2017-06-29 3M Innovative Properties Company Flow govenors for use in medicinal inhalers
EP3393563B1 (en) 2015-12-21 2021-06-09 Kindeva Drug Delivery L.P. Flow governor assemblies for use in medicinal inhalers
USD808515S1 (en) 2016-04-05 2018-01-23 3M Innovative Properties Company Inhaler

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5826571A (en) * 1995-06-08 1998-10-27 Innovative Devices, Llc Device for use with metered dose inhalers (MDIS)
US6405727B1 (en) * 1997-05-23 2002-06-18 Pa Knowledge Limited Inhaler mechanism
SE9801078D0 (en) 1998-03-27 1998-03-27 Shl Medical Ab Inhaler
JP4350308B2 (en) * 1998-09-24 2009-10-21 アストラゼネカ・アクチエボラーグ Inhaler

Similar Documents

Publication Publication Date Title
EP1267973B1 (en) Inhaler
AU2001244903A1 (en) Inhaler
EP1267974B1 (en) Inhaler
US6823863B2 (en) Inhaler
EP1267971B1 (en) Inhaler
AU2001244904A1 (en) Inhaler
AU2001242944A1 (en) Inhaler
AU2001239648B2 (en) Inhaler
AU2001239648A1 (en) Inhaler
JP4616476B2 (en) Inhaler
US8225790B2 (en) Inhaler 624
EP1267975B1 (en) Inhaler
AU2001244905A1 (en) Inhaler